Kapidex - 54868-5998-0 - (dexlansoprazole)

Alphabetical Index


Drug Information of Kapidex

Product NDC: 54868-5998
Proprietary Name: Kapidex
Non Proprietary Name: dexlansoprazole
Active Ingredient(s): 30    mg/1 & nbsp;   dexlansoprazole
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Kapidex

Product NDC: 54868-5998
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022287
Marketing Category: NDA
Start Marketing Date: 20090305

Package Information of Kapidex

Package NDC: 54868-5998-0
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (54868-5998-0)

NDC Information of Kapidex

NDC Code 54868-5998-0
Proprietary Name Kapidex
Package Description 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (54868-5998-0)
Product NDC 54868-5998
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name dexlansoprazole
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20090305
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name DEXLANSOPRAZOLE
Strength Number 30
Strength Unit mg/1
Pharmaceutical Classes Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]

Complete Information of Kapidex


General Information